SYRE - Company ID 0001636282
As of 2026-07-09, Spyre Therapeutics, Inc. (SYRE) has a market capitalization of $8.58 B, making it the #1053 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-07-09 | $8.58 B |
| 2026-07-08 | $8.18 B |
| 2026-07-07 | $8.10 B |
| 2026-07-06 | $7.71 B |
| 2026-07-05 | $7.52 B |
| 2026-07-04 | $7.52 B |
| 2026-07-03 | $7.52 B |
| 2026-07-02 | $7.52 B |
| 2026-07-01 | $7.59 B |
| 2026-06-30 | $7.87 B |
| 2026-06-29 | $7.83 B |
| 2026-06-28 | $7.63 B |
As of 2026-07-09, Spyre Therapeutics, Inc. (SYRE) has a market capitalization of $8.58 B, making it the #1053 most valuable US-listed company.
Spyre Therapeutics, Inc. is the #1053 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-06-27 | $7.63 B |
| 2026-06-26 | $7.63 B |
| 2026-06-25 | $7.70 B |
| 2026-06-24 | $7.31 B |
| 2026-06-23 | $8.43 B |
| 2026-06-22 | $8.71 B |
| 2026-06-21 | $7.67 B |
| 2026-06-20 | $7.67 B |
| 2026-06-19 | $7.67 B |
| 2026-06-18 | $7.68 B |
| 2026-06-17 | $7.52 B |
| 2026-06-16 | $7.20 B |
| 2026-06-15 | $7.15 B |
| 2026-06-14 | $7.02 B |
| 2026-06-13 | $7.02 B |
| 2026-06-12 | $7.02 B |
| 2026-06-11 | $6.52 B |
| 2026-06-10 | $6.53 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.